Rhythm Pharmaceuticals Inc.
RYTM | NASDAQ
$105.02
-$5.66 (-5.11%)
At close: Nov 5, 2026, 4:00 PM ET
$105.00
-$0.02 (-0.02%)
After-hours:
Nov 5, 2026, 6:07 PM ET
TTM Period Ending | Q3 2026 Sep 30, 2026 | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 280.75M | 239.92M | 217.17M | 189.76M | 174.33M | 156.29M | 136.86M | 130.13M | 112.53M | 101.78M | 91.93M | 77.43M | 61.98M | 43.76M | 33.61M | 23.64M | 16.67M | 13.41M | 4.62M | 3.15M | 1.34M | 309K | 35K |
Cost of Revenue | 33.06M | 26.39M | 23M | 19.49M | 18.48M | 16.81M | 14.21M | 13.37M | 12.82M | 11.4M | 10.69M | 9.3M | 7.1M | 5.18M | 3.32M | 2.13M | 1.34M | 1.07M | 825K | 599K | 363K | 141K | 4K |
Gross Profit | 247.69M | 213.53M | 194.16M | 170.27M | 155.86M | 139.48M | 122.65M | 116.76M | 99.72M | 90.38M | 81.24M | 68.13M | 54.89M | 38.58M | 30.29M | 21.51M | 15.32M | 12.34M | 3.79M | 2.56M | 974K | 168K | 31K |
Operating Income | -187.25M | -200.63M | -197.37M | -192.02M | -186.21M | -177.44M | -172.62M | -265.51M | -265.52M | -265.58M | -271.71M | -184.35M | -185.19M | -180.51M | -179M | -179.16M | -188.04M | -193.02M | -188.35M | -170.06M | -154.14M | -144.19M | -135.67M |
Interest Income | 14.02M | 15.19M | 15.21M | 15.29M | 14.72M | 14.45M | 15.31M | 14.71M | 15.02M | 14.43M | 13.55M | 13.95M | 13.17M | 10.62M | 7.68M | 4.4M | 1.49M | 706K | 453K | 447K | 489K | 817K | 1.6M |
Pretax Income | -192.24M | -204.28M | -201.72M | -196.04M | -191.89M | -183.08M | -168.57M | -260.22M | -258.28M | -258.09M | -273.01M | -184.11M | -185.17M | -182.24M | -180.53M | -181.12M | -189.48M | -192.72M | -188.13M | -69.61M | -53.65M | -43.37M | -34.08M |
Net Income | -193.81M | -205.35M | -202.68M | -196.54M | -192.33M | -183.06M | -168.69M | -260.57M | -258.91M | -259.43M | -273.87M | -184.68M | -185.54M | -182.24M | -180.53M | -181.12M | -181.49M | -175.74M | -166.13M | -69.61M | -61.64M | -60.35M | -56.08M |
Selling & General & Admin | 255.27M | 240.95M | 219.45M | 194.94M | 175.59M | 158.54M | 149.01M | 144.3M | 138.55M | 133.65M | 127.28M | 117.53M | 111.47M | 102.94M | 95.22M | 92.03M | 86.71M | 82.28M | 75.42M | 68.49M | 60.61M | 54.39M | 47.85M |
Research & Development | 179.67M | 173.21M | 172.09M | 167.34M | 166.48M | 158.38M | 146.09M | 237.59M | 226.31M | 221.95M | 225.48M | 134.95M | 128.61M | 116.15M | 114.07M | 108.63M | 116.66M | 123.08M | 116.73M | 104.13M | 94.51M | 89.96M | 87.86M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 434.94M | 414.16M | 391.54M | 362.28M | 342.07M | 316.92M | 295.28M | 382.26M | 365.23M | 355.97M | 352.95M | 252.48M | 240.08M | 219.09M | 209.28M | 200.66M | 203.37M | 205.36M | 192.14M | 172.61M | 155.12M | 144.36M | 135.7M |
Interest Expense | 18.23M | 18.48M | 19.76M | 20.58M | 21.42M | 21.92M | 20.7M | 20.05M | 19.15M | 17.06M | 15.76M | 14.06M | 12.52M | 11.52M | 8.26M | 5.2M | 2.19M | 46K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 323K | 323K | 323K |
Cost & Expenses | 467.99M | 440.55M | 414.54M | 381.77M | 360.54M | 333.73M | 309.49M | 395.63M | 378.05M | 367.37M | 363.64M | 261.78M | 247.18M | 224.27M | 212.61M | 202.8M | 204.71M | 206.43M | 192.97M | 173.21M | 155.48M | 144.5M | 135.71M |
Income Tax Expense | 1.57M | 1.07M | 962K | 497K | 438K | -17K | 125K | 345K | 631K | 1.34M | 864K | 564K | 368K | n/a | n/a | n/a | -7.99M | -16.98M | -22.01M | n/a | 7.99M | 16.98M | 22.01M |
Shares Outstanding (Basic) | 69.05M | 68.59M | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.25M | 50.27M | 50.25M | 50.21M | 47.64M |
Shares Outstanding (Diluted) | 69.05M | 68.59M | 67.97M | 66.88M | 64.35M | 63.68M | 63.06M | 61.6M | 61.22M | 61.01M | 60.14M | 59.21M | 57.87M | 56.87M | 56.71M | 56.3M | 51.4M | 50.4M | 50.33M | 50.27M | 50.25M | 50.21M | 48.5M |
EPS (Basic) | -2.90 | -3.11 | -3.13 | -3.11 | -3.10 | -2.99 | -2.77 | -4.31 | -4.29 | -4.34 | -4.63 | -3.19 | -3.24 | -3.31 | -3.38 | -3.52 | -3.62 | -3.49 | -3.30 | -1.33 | -1.27 | -1.34 | -1.35 |
EPS (Diluted) | -2.90 | -3.11 | -3.13 | -3.11 | -3.10 | -2.99 | -2.77 | -4.31 | -4.29 | -4.34 | -4.63 | -3.19 | -3.24 | -3.31 | -3.38 | -3.52 | -3.62 | -3.49 | -3.30 | -1.35 | -1.29 | -1.36 | -1.37 |
EBITDA | -173.24M | -184.72M | -180.75M | -174.12M | -169.02M | -159.64M | -146.33M | -238.61M | -237.53M | -239.38M | -255.54M | -168.29M | -170.86M | -168.93M | -170.49M | -174.25M | -185.74M | -191.25M | -186.83M | -168.61M | -152.97M | -143.3M | -134.95M |
EBIT | -174.01M | -185.8M | -181.96M | -175.46M | -170.47M | -161.17M | -147.87M | -240.18M | -239.13M | -241.03M | -257.25M | -170.05M | -172.65M | -170.72M | -172.27M | -175.92M | -187.29M | -192.68M | -188.13M | -169.77M | -153.98M | -144.17M | -135.67M |
Depreciation & Amortization | 775K | 1.08M | 1.21M | 1.34M | 1.45M | 1.53M | 1.54M | 1.56M | 1.6M | 1.65M | 1.71M | 1.76M | 1.78M | 1.78M | 1.78M | 1.67M | 1.56M | 1.43M | 1.31M | 1.16M | 1.01M | 868K | 724K |
Add to Watchlist
Select watchlists to add or remove RYTM